Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

A recent review and meta-analysis of semaglutide studies found that this drug can significantly reduce the risk of ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

The quick answer is, it's complicated. Number one, quality. Number three, delay of the product. because it's no longer ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

Groundbreaking research reveals how a popular diabetes and weight loss medication might offer unexpected help for those dealing with alcohol challenges.